Acne.org Products
Nitric Oxide Proven Safe for Acne Treatment
A recent study has proven that nitric oxide is safe to reduce acne when lowering inflammation and killingmicroorganisms. The phase one studyconducted by Novan Therapeutics, assessed the pharmacokinetics and safety of the company's SB204gel on 18 subjects with moderate to severe acnevulgaris.
Subjects received SB204 8% or a vehicle gel twice daily on their chests, backs and faces during the first five-day treatment period. Serial blood samples were collected on days one and five and analyzed for systematic exposure. After nine days, subjects received the alternate treatment over five days with the same blood sampling schedule. Plasma samples were analyzed for hMAP3 by liquid chromatography-mass spectrophotometry instrumental analysis and for nitrate by liquid chromatography.
Of the 10 females and eight males who enrolled, 16 completed the study. Both the active and vehicle gel left no changes in hematology, methemoglobin, chemistry or other labs. Additionally, treated subjects showed no difference in nitrate concentration and showed no safety issues.
According to the companys results,plasma nitrate levels were bioequivalent in subjects treated with the vehicle gelor NVN1000, a nitric oxide-releasing drug in SB204. The outcome also proved subjects utilizing SB204 8% under maximal use conditions were not associated with systematic exposure to hMAP3, a marker to NVN1000.
After these results confirming the safety of the nitric oxide gel, the company will move forward with phase two testing on 200 patients, expected in latter 2015. The phase three clinical trials are expected in 2016.
SB204
SB204, the Companys lead drug candidate for the treatment of acne vulgaris, is in late stage clinical development with Phase 3 top-line results expected in 1H 2017. We believe that SB204 has the potential to redefine the standard of care in acne vulgaris, and if approved will be the first new chemical entity specifically developed for the treatment of acne vulgaris in more than 20 years.
SB204 Clinical Trial Results
- Statistically significant efficacy with SB204 4% when compared to vehicle in both inflammatory and non-inflammatory lesionendpoints
- Clear separation between active andvehicle
- Good cutaneous tolerability
- Once daily treatment that is non-inferior to twice daily
- No measureable systemic exposure under maximal use conditions in moderate-to-severe acne patients
Click here to learn more about clinical trial enrollment
If it will work just as great as if not better than isotretinoin without the harmful side effects, this could be the answer to all of our problems. According to their website, this medication will do everything that isotretinoin can do: reduces sebum (most importantly), affects keratinocytes, anti-inflammatory, antimicrobial, and avoids resistance.
